Proteinuria
221 results
1 - 100
Proteinuria 
Steroids = placebo in preventing proteinuria in kids with HSP
Angiotensin‐converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease- Non-immunosuppressive treatment for IgA nephropathy
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Renal disease in children (nephrotic and nephritic syndrome)
- Glomerulonephrites
- Kidney biopsy
- IgA nephropathy
- Interpretation of urine test results in children
- Henoch-Schönlein purpura
- Increased blood creatinine concentration, eGFR and renal function tests
- Nephrotic syndrome
- Non‐immunosuppressive treatment for IgA nephropathy
- Pentoxifylline for diabetic kidney disease
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease
- Treatment of chronic renal failure
- More intensive BP lowering may prevent ESKD in selected proteinuric patients with CKD
- Time to resolution of hypertension after preeclampsia
- Steroids associated with increased risk of adverse outcomes in adults with IgA nephropathy
- Prostaglandin E1 for preventing the progression of diabetic kidney disease: Cochrane systematic review
- Interventions for preventing and treating kidney disease in IgA vasculitis (Henoch-Schönlein purpura)
- Extended study with a lower dose of steroids reports overall benefit for adults with IgA nephropathy
- Vasculitides
- Epidemic nephropathy
- Immunosuppressive therapy for IgA nephropathy in children
- Reporting estimated glomerular filtration rate (GFR) may not improve outcomes
- Clinical prediction of adverse outcomes in women with preeclampsia (PIERS)
- Induction of labor may be beneficial at 36 weeks with HTN
- Expectant management of hypertensive disorders less harmful for neonates until 37 weeks' gestation
- Interventions for chronic kidney disease in people with sickle cell disease
- Haematuria
- USPSTF 2017 recommends screening for preeclampsia via blood pressure measurements (B recommendation)
- Immunosuppressive agents for treating IgA nephropathy
- USPSTF 2023: Screen pregnant persons for hypertensive disorders throughout pregnancy (B recommendation)
- Guideline: When to screen for and treat chronic kidney disease
- Early-onset preeclampsia associated with increased risk of critical congenital heart defects
- Interventions for preventing and treating kidney disease in IgA vasculitis
- Cholesterol embolization
- Statins for people with chronic kidney disease not requiring dialysis
- Urinalysis and bacterial culture
- Acute kidney injury
- First-trimester vaginal progesterone results in lower rates of hypertensive disorders of pregnancy and preeclampsia
- Angiogenesis-inhibitors for metastatic thyroid cancer: Cochrane systematic review
- Interventions for weight loss in overweight or obese people with chronic kidney disease
- Systemic lupus erythematosus (SLE)
- Amyloidosis
- Eye symptoms and signs of systemic diseases
- Definition and diagnosis of dyslipidaemias
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Disease-specific signs and symptoms in patients with inflammatory joint diseases
- Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome: Cochrane systematic review
- Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease: Cochrane systematic review